Etrasimod
CAS No. 1206123-37-6
Etrasimod ( APD334;APD-334;APD 334 )
Catalog No. M10751 CAS No. 1206123-37-6
Etrasimod (APD334) is a potent, selective, centrally available S1P1 receptor antagonist with β-arrestin EC50 of 6.1 nM, internalizes human S1P1 in CHO cells expressing HA tagged S1P1 with IC50 of 1.88 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 61 | Get Quote |
|
5MG | 104 | Get Quote |
|
10MG | 172 | Get Quote |
|
25MG | 332 | Get Quote |
|
50MG | 500 | Get Quote |
|
100MG | 628 | Get Quote |
|
200MG | 895 | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEtrasimod
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtrasimod (APD334) is a potent, selective, centrally available S1P1 receptor antagonist with β-arrestin EC50 of 6.1 nM, internalizes human S1P1 in CHO cells expressing HA tagged S1P1 with IC50 of 1.88 nM.
-
DescriptionEtrasimod (APD334) is a potent, selective, centrally available S1P1 receptor antagonist with β-arrestin EC50 of 6.1 nM, internalizes human S1P1 in CHO cells expressing HA tagged S1P1 with IC50 of 1.88 nM; produces robust lymphocyte lowering effect (IC50=0.1 uM in mice), shows effectivity in mouse experimental autoimmune encephalomyelitis (EAE) model of MS and a rat collagen induced arthritis (CIA) model, orally active.Irritable Bowel Syndrome Phase 2 Clinical
-
SynonymsAPD334;APD-334;APD 334
-
PathwayGPCR/G Protein
-
TargetLysophospholipid Receptor
-
RecptorLysophospholipid Receptor
-
Research AreaOther Indications
-
IndicationIrritable Bowel Syndrome
Chemical Information
-
CAS Number1206123-37-6
-
Formula Weight457.48
-
Molecular FormulaC26H26F3NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 28 mg/mL
-
SMILESC1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CCC5CC(=O)O)C(F)(F)F
-
Chemical NameCyclopent[b]indole-3-acetic acid, 7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydro-, (3R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Buzard DJ, et al. ACS Med Chem Lett. 2014 Nov 4;5(12):1313-7.
2. Peyrin-Biroulet L, et al. Autoimmun Rev. 2017 May;16(5):495-503.
3. Nielsen OH, et al. Expert Opin Investig Drugs. 2016 Jun;25(6):709-18.
2. Peyrin-Biroulet L, et al. Autoimmun Rev. 2017 May;16(5):495-503.
3. Nielsen OH, et al. Expert Opin Investig Drugs. 2016 Jun;25(6):709-18.
molnova catalog
related products
-
ASP6432
ASP6432 (ASP-6432) is a potent and selective antagonist of LPA1 receptor, does-dependently inhibits LPA-stimulated increase in intracellular calcium ion with IC50 of 11 nM.
-
Fingolimod
An immunomodulatory agent can be phosphorylated by SphK, then functions as a potent agonist of S1P receptors (S1P1/3/4/5) with EC50 of 0.3-5 nM.
-
Ponesimod
A potent, selective, orally active S1P1 receptor agonist with EC50 of 9.1 nM; shows weak activity on S1P3 (EC50=123 nM).